Angelman syndrome

15,338views

Angelman syndrome

Watch later

Watch later

Necrosis and apoptosis
Inheritance patterns
Cervical cancer
Innate immune system
B- and T-cell memory
B-cell development
MHC class I and MHC class II molecules
Inflammation
Cell-mediated immunity of natural killer and CD8 cells
T-cell development
Introduction to the immune system
Cell-mediated immunity of CD4 cells
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Development of the placenta
Development of twins
Development of the umbilical cord
Development of the fetal membranes
Mendelian genetics and punnett squares
Hardy-Weinberg equilibrium
Inheritance patterns
Independent assortment of genes and linkage
Evolution and natural selection
Down syndrome (Trisomy 21)
Edwards syndrome (Trisomy 18)
Patau syndrome (Trisomy 13)
Fragile X syndrome
Huntington disease
Myotonic dystrophy
Friedreich ataxia
Turner syndrome
Klinefelter syndrome
Prader-Willi syndrome
Angelman syndrome
Beckwith-Wiedemann syndrome
Cri du chat syndrome
Williams syndrome
Alagille syndrome (NORD)
Achondroplasia
Polycystic kidney disease
Familial adenomatous polyposis
Familial hypercholesterolemia
Hereditary spherocytosis
Li-Fraumeni syndrome
Marfan syndrome
Multiple endocrine neoplasia
Neurofibromatosis
Tuberous sclerosis
von Hippel-Lindau disease
Albinism
Cystic fibrosis
Gaucher disease (NORD)
Glycogen storage disease type I
Glycogen storage disease type II (NORD)
Glycogen storage disease type III
Glycogen storage disease type IV
Glycogen storage disease type V
Hemochromatosis
Mucopolysaccharide storage disease type 1 (Hurler syndrome) (NORD)
Krabbe disease
Leukodystrophy
Niemann-Pick disease types A and B (NORD)
Niemann-Pick disease type C
Primary ciliary dyskinesia
Phenylketonuria (NORD)
Sickle cell disease (NORD)
Tay-Sachs disease (NORD)
Alpha-thalassemia
Beta-thalassemia
Wilson disease
Alport syndrome
X-linked agammaglobulinemia
Fabry disease (NORD)
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Hemophilia
Mucopolysaccharide storage disease type 2 (Hunter syndrome) (NORD)
Lesch-Nyhan syndrome
Muscular dystrophy
Ornithine transcarbamylase deficiency
Wiskott-Aldrich syndrome
Mitochondrial myopathy
Autosomal trisomies: Pathology review
Muscular dystrophies and mitochondrial myopathies: Pathology review
Miscellaneous genetic disorders: Pathology review
Complement system
Liver anatomy and physiology
Cholestatic liver disease
Gallstones
Liver histology
Cirrhosis: Clinical
Non-alcoholic fatty liver disease
Anatomy of the pelvic girdle
Fascia, vessels and nerves of the upper limb
Anatomy of the brachial plexus
Cell cycle
Mitosis and meiosis
Metaplasia and dysplasia
Gel electrophoresis and genetic testing
DNA mutations
Heart failure

Transcript

Watch video only

Content Reviewers

Angelman syndrome is a genetic disorder that causes intellectual and developmental delay, seizures, frequent laughter, and ataxia, or poor control of voluntary movements.

Now, it happens when a gene on chromosome 15 called UBE3A is not expressed, or transcribed into messenger RNA.

UBE3A stands for ubiquitin-protein ligase E3A, and the protein it codes for is called E6AP or E6-associated protein.

The job of E6AP is to go around tagging, or attaching, a tiny protein called ubiquitin to other proteins, a process called ubiquitination.

Once that happens, the ubiquitinated protein is degraded by the proteasome, a part of the cell’s recycling machinery.

It’s kind of painting an orange U on a tree so that a lumberjack knows to chop it down.

So E6 associated protein has an important job, and it turns out that the region of chromosome 15 around UBE3A is imprinted, imprinting refers to gene expression that’s dependent on the parent of origin of a gene.

This means that either the maternally derived or paternally derived copy of the gene is silenced.

This differs from most genes in the genome, where both the maternal and paternal copies are expressed.

Normally, in the brain, only the maternally derived copy of UBE3A is expressed, while the paternal copy is silenced, unfortunately this process of imprinting leaves the maternal copy of UBE3A vulnerable.

So with the paternal copy of the gene imprinted, and epigenetically silenced, you’ve only got the maternal copy left.

So this means that if anything happens to the maternal copy, the result is Angelman syndrome.

There are a few different types of mutations that can cause Angelman syndrome.

The most common one is a deletion of a couple million base pairs of DNA on the maternal copy of chromosome 15 which includes UBE3A.

Sometimes the deletion overlaps a nearby gene called OCA2, which codes for a pigment that gives color to eye, hair, and skin.

As a result of this, these Angelman syndrome patients can have a light complexion.

A second way is a mutation within the maternal copy of UBE3A, making the protein ineffective.

A third way to get Angelman syndrome is when the entire maternal chromosome 15 is absent and instead there’s an extra copy of the paternal chromosome 15.

This scenario is called paternal uniparental disomy, which means that one parent – the father – contributed two of the same chromosome while the mother contributed none.

Key Takeaways

Angelman syndrome (AS) is a genetic neurodevelopmental disorder characterized by problems with motor skills, speech, developmental delay, and learning disabilities. People with AS typically have happy dispositions and frequently laugh or smile, even when they are not engaged in activities that would typically elicit such reactions.

Most individuals with AS do not develop fluent speech, have sleep disturbance, and usually have seizures. People with AS typically have a normal life expectancy and have the potential to improve on some self-help skills with proper supportive care.